Search results for " vaccine production"

Article Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
Cell-based vaccine production with well-characterized processes can be a solution to meeting the capacity requirements. It also has its advantage in shorter production time compared to egg-based produ…

Article Vaccine Development and Production Challenges Manufacturers
Mar 01, 2015 By Jill Wechsler BioPharm International Volume 3, Issue 28 Vaccines are front-page news these days. Researchers are advancing new vaccines for Ebola and other devastating di…

Article Approaches for Flexible Manufacturing Facilities in Vaccine Production
President's Council of Advisors on Science and Technology, "Report to the President on Reengineering the Influenza Vaccine Production Enterprise to Meet the Challenges of Pandemic Influenza" (Aug. 201…

Article Accelerated flavivirus vaccine production with modern tools and solutions
This white paper gives an overview of modern tools and solutions, adding flexibility and speed to both upstream and downstream operations in flavivirus vaccine production. Single-use production bi…

Article Flavivirus Vaccine: Accelerate Development and Production with Modern Tools and Solutions
In addition, vaccine production can be both costly and difficult to scale to meet market demands. This article gives an overview of modern tools and solutions, adding flexibility and speed to both ups…

Poster Development of a chemically defined medium for virus vaccine production in a duck suspension cell line
A project was initiated to improve the production process for viral vaccines through the use of the EB66® cell line derived from duck embryonic stem cells and proprietary to Valneva. The primary goa…

Poster Biacore™ systems in vaccine development and production
The growing public awareness of a potential pandemic requiring rapid treatment of millions of healthy individuals has spurred renewed interest in vaccines. Vaccination campaigns mean that often very…

Webcast Modernizing legacy vaccine processes to improve productivity and purity
Traditionally, the production of meningococcal A, C, W, Y vaccine has involved the use of phenol to rid the sample of protein material. Since the use of phenol is no longer acceptable, GE developed …

Article Faster Flavivirus Vaccine Production
Viral vaccines need to be produced fast and in large quantities. Routine immunizations and preventive campaigns, like stockpiling in response to emergencies, involve millions of doses, and speed is es…

Article Achieve Scalable Viral Vector Production
In our tutorial series on viral vector production, GE scientists share their insights on virus production and how to tackle viral vector manufacturing challenges. In this episode, a scalable productio…

Next Page